Found: 9
Select item for more details and to access through your institution.
NICE's Cost-Effectiveness Range: Should it be Lowered?
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 613, doi. 10.1007/s40273-014-0158-6
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Interventions for Tuberculosis Control: DALYs Versus QALYs.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 617, doi. 10.1007/s40273-014-0159-5
- By:
- Publication type:
- Article
Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 627, doi. 10.1007/s40273-014-0155-9
- By:
- Publication type:
- Article
A Review of the Economics of Treating Clostridium difficile Infection.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 639, doi. 10.1007/s40273-014-0161-y
- By:
- Publication type:
- Article
Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 651, doi. 10.1007/s40273-014-0160-z
- By:
- Publication type:
- Article
Barriers to the Uptake of Biosimilars and Possible Solutions: A Belgian Case Study.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 681, doi. 10.1007/s40273-014-0163-9
- By:
- Publication type:
- Article
Mapping EQ-5D Utility Scores from the PedsQL™ Generic Core Scales.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 693, doi. 10.1007/s40273-014-0153-y
- By:
- Publication type:
- Article
Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Cost-Effectiveness Analysis of Docetaxel Versus Weekly Paclitaxel in Adjuvant Treatment of Regional Breast Cancer in New Zealand.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 707, doi. 10.1007/s40273-014-0154-x
- By:
- Publication type:
- Article